- Home
- GRVY vs LAB Comparison
GRVY vs LAB Comparison
Compare GRVY & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRVY | LAB |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.1M | 449.9M |
| IPO Year | 2005 | 2011 |
Fundamental Metrics
Financial Performance| Metric | GRVY | LAB |
|---|---|---|
| Price | $56.70 | $1.46 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.35 |
| AVG Volume (30 Days) | 15.0K | ★ 2.0M |
| Earning Date | 11-07-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.02 | N/A |
| Revenue | ★ $399,496,744.00 | $169,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.02 | ★ N/A |
| Revenue Growth | 12.13 | ★ 79.77 |
| 52 Week Low | $53.12 | $0.92 |
| 52 Week High | $70.00 | $2.25 |
Technical Indicators
Market Signals| Indicator | GRVY | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 50.66 | 62.34 |
| Support Level | $55.10 | $1.43 |
| Resistance Level | $58.44 | $1.51 |
| Average True Range (ATR) | 1.40 | 0.08 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 67.50 | 66.67 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.